637 related articles for article (PubMed ID: 28553112)
21. A tumor-specific cleavable nanosystem of PEG-modified C60@Au hybrid aggregates for radio frequency-controlled release, hyperthermia, photodynamic therapy and X-ray imaging.
Shi J; Chen Z; Wang L; Wang B; Xu L; Hou L; Zhang Z
Acta Biomater; 2016 Jan; 29():282-297. PubMed ID: 26485168
[TBL] [Abstract][Full Text] [Related]
22. Novel Core-Interlayer-Shell DOX/ZnPc Co-loaded MSNs@ pH-Sensitive CaP@PEGylated Liposome for Enhanced Synergetic Chemo-Photodynamic Therapy.
Ma J; Wu H; Li Y; Liu Z; Liu G; Guo Y; Hou Z; Zhao Q; Chen D; Zhu X
Pharm Res; 2018 Feb; 35(3):57. PubMed ID: 29423532
[TBL] [Abstract][Full Text] [Related]
23. Single-walled carbon nanotube-loaded doxorubicin and Gd-DTPA for targeted drug delivery and magnetic resonance imaging.
Yan C; Chen C; Hou L; Zhang H; Che Y; Qi Y; Zhang X; Cheng J; Zhang Z
J Drug Target; 2017 Feb; 25(2):163-171. PubMed ID: 27499100
[TBL] [Abstract][Full Text] [Related]
24. NIR-driven Smart Theranostic Nanomedicine for On-demand Drug Release and Synergistic Antitumour Therapy.
Zhao P; Zheng M; Luo Z; Gong P; Gao G; Sheng Z; Zheng C; Ma Y; Cai L
Sci Rep; 2015 Sep; 5():14258. PubMed ID: 26400780
[TBL] [Abstract][Full Text] [Related]
25. Design of pH/reduction dual-responsive nanoparticles as drug delivery system for DOX: Modulating controlled release behavior with bimodal drug-loading.
Liu P; Zhang R; Pei M
Colloids Surf B Biointerfaces; 2017 Dec; 160():455-461. PubMed ID: 28985607
[TBL] [Abstract][Full Text] [Related]
26. NIR-/pH-Responsive drug delivery of functionalized single-walled carbon nanotubes for potential application in cancer chemo-photothermal therapy.
Wang L; Shi J; Jia X; Liu R; Wang H; Wang Z; Li L; Zhang J; Zhang C; Zhang Z
Pharm Res; 2013 Nov; 30(11):2757-71. PubMed ID: 23765399
[TBL] [Abstract][Full Text] [Related]
27. Dual-triggered drug-release vehicles for synergistic cancer therapy.
Tu TY; Yang SJ; Tsai MH; Wang CH; Lee SY; Young TH; Shieh MJ
Colloids Surf B Biointerfaces; 2019 Jan; 173():788-797. PubMed ID: 30384276
[TBL] [Abstract][Full Text] [Related]
28. Cit/CuS@Fe
Zhu X; Huang H; Zhang Y; Zhang H; Hou L; Zhang Z
J Biomater Appl; 2017 Feb; 31(7):1010-1025. PubMed ID: 28178904
[TBL] [Abstract][Full Text] [Related]
29. Luminescent/magnetic PLGA-based hybrid nanocomposites: a smart nanocarrier system for targeted codelivery and dual-modality imaging in cancer theranostics.
Shen X; Li T; Chen Z; Geng Y; Xie X; Li S; Yang H; Wu C; Liu Y
Int J Nanomedicine; 2017; 12():4299-4322. PubMed ID: 28652734
[TBL] [Abstract][Full Text] [Related]
30. Near-Infrared Fluorescent Dye-Decorated Nanocages to Form Grenade-like Nanoparticles with Dual Control Release for Photothermal Theranostics and Chemotherapy.
Lin CY; Shieh MJ
Bioconjug Chem; 2018 Apr; 29(4):1384-1398. PubMed ID: 29505243
[TBL] [Abstract][Full Text] [Related]
31. Theranostic, pH-Responsive, Doxorubicin-Loaded Nanoparticles Inducing Active Targeting and Apoptosis for Advanced Gastric Cancer.
Ma H; Liu Y; Shi M; Shao X; Zhong W; Liao W; Xing MM
Biomacromolecules; 2015 Dec; 16(12):4022-31. PubMed ID: 26477267
[TBL] [Abstract][Full Text] [Related]
32. A pharmaceutical study of doxorubicin-loaded PEGylated nanoparticles for magnetic drug targeting.
Gautier J; Munnier E; Paillard A; Hervé K; Douziech-Eyrolles L; Soucé M; Dubois P; Chourpa I
Int J Pharm; 2012 Feb; 423(1):16-25. PubMed ID: 21703340
[TBL] [Abstract][Full Text] [Related]
33. Near-infrared light remote-controlled intracellular anti-cancer drug delivery using thermo/pH sensitive nanovehicle.
Qin Y; Chen J; Bi Y; Xu X; Zhou H; Gao J; Hu Y; Zhao Y; Chai Z
Acta Biomater; 2015 Apr; 17():201-9. PubMed ID: 25644449
[TBL] [Abstract][Full Text] [Related]
34. Tumor-penetrating Peptide Conjugated and Doxorubicin Loaded T
Gao L; Yu J; Liu Y; Zhou J; Sun L; Wang J; Zhu J; Peng H; Lu W; Yu L; Yan Z; Wang Y
Theranostics; 2018; 8(1):92-108. PubMed ID: 29290795
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy.
Mosafer J; Abnous K; Tafaghodi M; Mokhtarzadeh A; Ramezani M
Eur J Pharm Biopharm; 2017 Apr; 113():60-74. PubMed ID: 28012991
[TBL] [Abstract][Full Text] [Related]
36. Bile acid-conjugated chondroitin sulfate A-based nanoparticles for tumor-targeted anticancer drug delivery.
Lee JY; Chung SJ; Cho HJ; Kim DD
Eur J Pharm Biopharm; 2015 Aug; 94():532-41. PubMed ID: 26149228
[TBL] [Abstract][Full Text] [Related]
37. Surface-Modified Nanoerythrocyte Loading DOX for Targeted Liver Cancer Chemotherapy.
Wang Y; Chen X; He D; Zhou Y; Qin L
Mol Pharm; 2018 Dec; 15(12):5728-5740. PubMed ID: 30359027
[TBL] [Abstract][Full Text] [Related]
38. Gold nanoparticles modified hollow carbon system for dual-responsive release and chemo-photothermal synergistic therapy of tumor.
Zhao Q; Yang Y; Wang H; Lei W; Liu Y; Wang S
J Colloid Interface Sci; 2019 Oct; 554():239-249. PubMed ID: 31301524
[TBL] [Abstract][Full Text] [Related]
39. Novel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapy.
Xia Y; Xu T; Wang C; Li Y; Lin Z; Zhao M; Zhu B
Int J Nanomedicine; 2018; 13():143-159. PubMed ID: 29317822
[TBL] [Abstract][Full Text] [Related]
40. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
Moosavian SA; Abnous K; Badiee A; Jaafari MR
Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
